FDA inspection
Lifepharma FZE: FDA inspection ending Nov 24, 2022
FDA inspection 1191272 · Voluntary Action Indicated (VAI) · Dubai
Key facts
| Inspection ID | 1191272 |
|---|---|
| Firm | Lifepharma FZE |
| FEI number | 3011786267 |
| Address | Near Round-About 13, Plot No MO0502, Jebel Ali Free Zone, Jebel Ali |
| City | Dubai |
| Country | United Arab Emirates |
| Fiscal year | 2023 |
| Inspection end date | Nov 24, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data